Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03958409 · ClinicalTrials.gov registry record · NA

Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients

A NA study of Kidney Transplant; Complications and Skeletal Anomalies, sponsored by Yale University.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT03958409 is a NA study of Kidney Transplant; Complications and Skeletal Anomalies that has completed, run by Yale University. The registered enrollment target is 8 participants, below the 121-participant average among 19 other Kidney Transplant; Complications trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03958409, a NA study of Kidney Transplant; Complications and Skeletal Anomalies, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

There is a well-documented increased risk for disordered mineral bone homeostasis in Kidney Transplant Recipients (KTRs) when compared to the general population, leading to a markedly increased risk for fragility fractures and their associated morbidity and mortality. A more uniform and rigorous evaluation of bone and mineral homeostasis,than is afforded to patients under "normal care", will result in better clinical outcomes in KTRs.

Interventions

  • DIAGNOSTIC_TEST measurements to evaluate metabolic bone disease
  • DIAGNOSTIC_TEST standard care

Study Locations (1)

Connecticut

  • Yale Transplantation Center/Yale-New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2018-12-12
Est. Completion 2021-12-02
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03958409

The ClinicalTrials.gov registry entry for NCT03958409 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 121-participant average among 19 other Kidney Transplant; Complications trials with a reported enrollment target (93% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Kidney Transplant; Complications appearing as the primary indexed condition, and to 2 interventions - of which measurements to evaluate metabolic bone disease is the first listed.

NCT03958409 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03958409 about?

NCT03958409 is a clinical study titled "Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients". There is a well-documented increased risk for disordered mineral bone homeostasis in Kidney Transplant Recipients (KTRs) when compared to the general population, leading to a markedly increased risk for fragility fractures and their associated morbidity and mortality. A more uniform and rigorous eva...

What is the current status of trial NCT03958409?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-12-12. Estimated completion is 2021-12-02.

What conditions does trial NCT03958409 study?

This clinical trial studies the following conditions: Kidney Transplant; Complications, Skeletal Anomalies.

What interventions are being tested in trial NCT03958409?

The interventions under investigation include: measurements to evaluate metabolic bone disease (DIAGNOSTIC_TEST), standard care (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03958409?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03958409 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Transplant; Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.